Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Conditions

Neoplasms 2Stroke 1Pain 1Neoplasms, Second Primary 1Mental Disorders 1Learning Disabilities 1Feeding and Eating Disorders 1Cancer Pain 1Brain Neoplasms 1

Interventions

pembrolizumab 180Gemcitabine 168Paclitaxel 150Carboplatin 134Bevacizumab 126Cisplatin 113Docetaxel 112Cyclophosphamide 109Exercise 97Nivolumab 93Fluorouracil 88Capecitabine 85Dexamethasone 81Irinotecan 74Radiotherapy 68Oxaliplatin 68Pemetrexed 66Standard of Care 64Leucovorin 63Cetuximab 59Sorafenib 53Erlotinib Hydrochloride 53Drug Therapy 53Blood Specimen Collection 51Doxorubicin 50atezolizumab 48trametinib 47Ipilimumab 47Albumin-Bound Paclitaxel 44130-nm albumin-bound paclitaxel 42

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Neoplasms × Animal Assisted Therapy × Clear all
NCT00431639 2019-04-11

Effects of Pet Therapy on Pain in Cancer Patients

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
36 enrolled

Cancer Pain, Neoplasms, Pain

NCT01441674 2014-02-14

AAT

Children's Hospitals and Clinics of Minnesota

Phase 1/2 Completed
30 enrolled

Feeding and Eating Disorders, Mental Disorders, Learning Disabilities, Neoplasms, Stroke

Data powered by HemOnc (CC BY 4.0) Colophon âš¡